Market Tracker

04/25 4:06am ET

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

8.00
Data as of Apr 24
 -0.06 / -0.74%
Today’s Change
4.45
Today|||52-Week Range
10.55
+6.10%
Year-to-Date
No recent news for Supernus Pharmaceuticals Inc.

Today’s Trading

Previous close8.06
Today’s open8.14
Day’s range-- - --
Volume323,171
Average volume (3 months)547,162
Market cap$356.1M
Dividend yield--
Data as of 04/24/2014

Growth & Valuation

Earnings growth (last year)-6.62%
Earnings growth (this year)+62.72%
Earnings growth (next 5 years)--
Revenue growth (last year)+712.09%
P/E ratioNM
Price/Sales19.98
Price/Book10.12

Competitors

 Today’s
change
Today’s
% change
ZGNXZogenix Inc+0.03+1.07%
SNTASynta Pharmaceutical...-0.04-0.95%
RPRXRepros Therapeutics ...-0.32-1.83%
SNSSSunesis Pharmaceutic...-0.07-1.31%
Data as of 3:59pm ET, 04/24/2014

Financials

Next reporting dateJune 5, 2014
EPS forecast (this quarter)-$0.41
Annual revenue (last year)$12.0M
Annual profit (last year)-$92.3M
Net profit margin-767.73%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Founder
Jack A. Khattar
Chief Financial Officer &
Vice President
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts